Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277277 · ClinicalTrials.gov registry record · NA
In-Home Weight Loss Program for Adults With Type 2 Diabetes Delivered by Interactive Cable Television Technology
A NA study, sponsored by Bastyr University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00277277: Completed NA study, sponsored by Bastyr University.
NCT00277277 is a NA study that has completed, run by Bastyr University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00277277, a NA study, has completed, sponsored by Bastyr University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The majority of patients with Type 2 Diabetes are obese and weight loss is known to improve diabetes outcomes and reduce the need for anti-diabetic medical. This 8-week Telehealth study will compare the effects of standard weight loss advice given in a clinic setting to weight loss advice delivered in the home using an interactive cable television technology called Healthium.
Interventions
- BEHAVIORAL Healthium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2004-08 |
| Est. Completion | 2005-09 |
| Phase | NA |
What the finished NCT00277277 record still lists
NCT00277277 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Healthium is the first listed.
NCT00277277 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00277277 about?
NCT00277277 is a clinical study titled "In-Home Weight Loss Program for Adults With Type 2 Diabetes Delivered by Interactive Cable Television Technology". The majority of patients with Type 2 Diabetes are obese and weight loss is known to improve diabetes outcomes and reduce the need for anti-diabetic medical. This 8-week Telehealth study will compare the effects of standard weight loss advice given in a clinic setting to weight loss advice delivered ...
What is the current status of trial NCT00277277?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2004-08. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00277277?
The interventions under investigation include: Healthium (BEHAVIORAL).
Who is sponsoring clinical trial NCT00277277?
This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00277277's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia